Ross Kayuha CEO
30+ years’ executive experience with successful IPO and acquisition.
Ronald Bracken COO
28 years’ of experience in medical device design and R&D. Most recently served as VP of R&D and Special Initiatives at C.R. Bard, including the development and launch of anti-infective medical devices.
Dr. Jed Johnson CTO
PhD in Materials Science and Engineering, and is a recognized expert on synthetic scaffolds for Tissue Engineering.
Dr. Krishna Mannava
Dr. Krishna Mannava is a Medical Director for Vascular Genesis and currently Chief of Surgery at Fairfield Medical Center as well as the director of vascular services there. He has a unique skill set that combines the latest minimally invasive endovascular techniques with traditional open surgical skills.
Vascular Genesis – RESI Conference
Jed Johnson and Ross Kayuha representing Vascular Genesis at the RESI Conference in Boston. Vascular Genesis was 1 of 40 teams chosen for the innovation challenge.